小児睡眠診断技術の臨床評価
The objective of this project is to gather research data and subsequently evaluate algorithms to demonstrate clinical efficacy of a novel sleep apnoea detection system in the paediatric population.
The Study will involve patients who will have been referred for diagnosis of sleep apnoea, and the ultimate aim will be to compare the output of a novel apnoea detection system against in -clinic polysomnography or cardio-respiratory polygraphy, assess acceptance of the novel system in the home environment, assess validity in patients on ventilation, and on a cohort with BMI SDS of 3 or more.
調査の概要
詳細な説明
The objective of this project is to gather research data and subsequently evaluate algorithms to demonstrate clinical efficacy of a novel sleep apnoea detection system in the paediatric population.
The Study will involve patients who will have been referred for diagnosis of sleep apnoea, and the ultimate aim will be to compare the output of a novel apnoea detection system against in -clinic polysomnography or cardio-respiratory polygraphy, assess acceptance of the novel system in the home environment, assess validity in patients on ventilation, and on a cohort with BMI SDS of 3 or more.
Patients who are referred to the clinic for the first and second group will spend one night's sleep in the clinic for group 1 and group 2. They will wear a polysomnography or cardio-respiratory polygraphy system (current goldstandard) and the novel device. At the end of the trial, we will compare the diagnosis results from both systems.
Patients who are referred for home diagnosis of sleep apnoea or overnight oximetry at home (group 3) will wear the standard clinical sleep test system and the novel device. At the end of the trial, the acceptability of the novel device will be assessed.
Patients who are on mechanical ventilation and referred for diagnosis of sleep apnoea in hospital or at home will wear the standard clinical sleep test system and the novel device. At the end of the trial, the validity of the diagnosis from the novel device will be assessed.
Patients who are referred for either at home or in hospital diagnosis of sleep apnoea with a BMI SDS score of 3 or more will wear the standard clinical sleep test system and the novel device. At the end of the trial, we will compare the diagnosis results from both systems.
研究の種類
入学 (推定)
連絡先と場所
研究連絡先
- 名前:Renard Pramono, PhD
- 電話番号:+447721 877020
- メール:renard@acurable.com
研究場所
-
-
-
Sheffield、イギリス、S10 2TH
- 募集
- Sheffield Children Hospital
-
コンタクト:
- Orsina Dessi
- 電話番号:+447721 877020
- メール:orsina@acurable.com
-
主任研究者:
- Heather Elphick
-
Southampton、イギリス
- 募集
- Southampton Children's Hospital
-
コンタクト:
- Orsina Dessi
-
主任研究者:
- Hazel Evans
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
サンプリング方法
調査対象母集団
all children who have been referred for a sleep test.
説明
Inclusion Criteria:
- Children older than one year old (older than eight years old for studies at-home) and below 18 years of age.
- Children who have been referred to a sleep clinic due to suspicion of sleep apnoea.
Exclusion Criteria:
- Patients whose parents/legal guardians/carers are not fluent in English, or who have special communication needs.
- Known allergy to the adhesive dressing.
- Patients with physical or mental impairments who would be too distressed with additional sensors on themselves.
- Patients with not enough space on the neck area to fit the sensor.
- Clinical problem in the area in which the device will be attached, eg skin condition ●. For patients conducting the study at home, patients with neurocognitive impairments which may increase the risk of them putting the sensor in their mouth, who do not have overnight carers
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 観測モデル:COHORT
- 時間の展望:PROSPECTIVE
コホートと介入
グループ/コホート |
介入・治療 |
|---|---|
|
test group
Test group will wear PSG |
The patient will wear the novel wearable paediatric device at the same time as polysmnography |
|
Novel wearable device
THis group will wear the novel device |
The patient will wear the novel wearable paediatric device at the same time as polysmnography |
|
Home
40 consecutive patients (plus/minus 30% to account for potential dropouts, invalid signals from the gold-standard), who will have been referred for at home diagnosis of sleep apnoea or overnight oximetry at home. Each site will recruit, in parallel, consecutive patients from the moment the first patient in this group is recruited at that site. Each subject whose parents are willing to take part in the trial and meets the inclusion criteria will be included in the study. Criteria for inclusion are children older than 8 years old and referral for overnight assessment for evaluation of possible sleep apnoea. Additionally, patients will be excluded from the study if the clinical team consider the child is too unwell or distressed to be approached or one of the exclusion criteria below. This patient cohort will be used to assess the acceptance of the AcuPebble technology in the home environment. |
The patient will wear the novel wearable paediatric device at the same time as polysmnography |
|
Ventilation
30 patients will be recruited (plus/minus 30% to account for potential dropouts, invalid signals from the gold-standard), who are on mechanical ventilation and have been referred for diagnosis of sleep apnoea. Each subject whose parents are willing to take part in the trial and meets the inclusion criteria will be included in the study. Criteria for inclusion are children older than 1 year old, referral for overnight assessment for evaluation or monitoring of sleep apnoea, and being on mechanical ventilation while conducting the study in hospital, or over 8 years old, referral for overnight assessment for evaluation or monitoring of sleep apnoea, and being on mechanical ventilation while conducting the study at home. Patients will be excluded from the study if the clinical team consider the child is too unwell or distressed to be approached or one of the exclusion criteria below. These patients will be included in a final analysis of diagnostic validity. |
The patient will wear the novel wearable paediatric device at the same time as polysmnography |
|
High BMI
75 patients will be recruited (plus/minus 30% to account for potential dropouts, or invalid signals from the gold-standard), who have a BMI SDS score of 3 or more and have been referred for either at-home or in-hospital diagnosis of sleep apnoea. Each subject whose parents are willing to take part in the trial and meets the inclusion criteria will be included in the study. If their study is to take place in the home, only children who are older than 8 will be included. If their study is to take place in hospital, children over the age of 1 will be included. Patients will be excluded from the study if the clinical team consider the child is too unwell or distressed to be approached or one of the exclusion criteria below. These patients will be included in a final analysis of sensitivity and specificity for this cohort. |
The patient will wear the novel wearable paediatric device at the same time as polysmnography |
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Specificity and sensitivity of novel device
時間枠:6 months
|
specificity and sensitivity of the output of the novel wearable device against polysomnography |
6 months
|
協力者と研究者
スポンサー
捜査官
- スタディディレクター:Ruth Kingshott, PhD、Sheffield Children's NHS Foundation Trust
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。